跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
捷诺达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sitagliptin Phosphate/metformin Hydrochloride Tablets
Approved
化学药品
Sitagliptin Phosphate/metformin Hydrochloride Tablets
MSD PHARMA (SINGAPORE) PTE. LTD.
🇨🇳 National Medical Products Administration
Approval Date
May 29, 2019
Approval ID
7MazXbDe0Se
Company
MSD PHARMA (SINGAPORE) PTE. LTD.
Type
化学药品
Approval Details
Approval Id
7MazXbDe0Se
Approval Number
国药准字J20171013
Generic Name
西格列汀二甲双胍片(Ⅰ)
Generic Name En
Sitagliptin Phosphate/metformin Hydrochloride Tablets
Trade Name
捷诺达
Drug Type
化学药品
Dosage Form
片剂
Strength
磷酸西格列汀50mg(以游离碱计)和盐酸二甲双胍500mg
Reg Date
2019-05-29
Company Name
MSD PHARMA (SINGAPORE) PTE. LTD.
Company Address
150 Beach Road, #31-00, Gateway West, Singapore 189720
Production Company Name
patheon puerto rico, inc. (manati)
Production Company Address
State Road #670 Km.2.7 Manati, Puerto Rico, 00674 United States
Company Detail Path
/organization/msd-pharma-singapore-pte-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 29, 2019
Approval ID
7MazXbDe0Se
Type
化学药品
Back to NMPA Approvals